prodchem
Aug 18, 2026
For most of the past two decades, the global chemical sector was a surprisingly strong shareholder-return story.
That has now changed dramatically.
According to McKinsey's latest chemicals capital-markets analysis, the sector consistently outperformed global equities from 2004 through 2023, but the past three years have effectively erased that 20-year period of excess performance.
The reversal is more than a normal cyclical downturn. Chemical companies are confronting a combination of structural overcapacity, weaker demand growth, high energy costs, regionalization, heavier regulation and massive capital requirements.
The result is a fundamental question for investors:
Was the chemical industry's historic outperformance a temporary cycle—or was it built on economic advantages that no longer exist to the same degree?
The chemical sector's long-term performance was supported by several powerful tailwinds.
Between 2003 and 2021, McKinsey estimates that the industry generated approximately 11% annual total shareholder returns, alongside improving ROIC and roughly 5% annual revenue growth.
Several factors drove that performance:
Rapid chemical demand growth in Asia
China's industrial expansion
Productivity improvements
Access to lower-cost feedstocks
The US shale-gas revolution
Portfolio repositioning
Stronger specialty-chemical economics
The industry benefited from a favorable combination of growth, improving returns on capital and expanding valuation multiples.
That combination has weakened.
The chemical industry's problem is not simply that earnings declined.
The underlying economics deteriorated.
McKinsey's analysis identifies several overlapping pressures:
Structural overcapacity
Modest demand growth
Falling margins
Heavy capital investment
High energy costs
Regionalization of supply chains
Increased Chinese self-sufficiency
Tougher environmental regulation
Over the past five years, chemical-sector growth was more than offset by heavy capital investment and declining margins. McKinsey calculates performance-driven TSR at only 1.6% annually, with multiple expansion bringing total TSR to about 2.6% annually.
That's a radically different value-creation model from the industry's earlier period.
China was one of the biggest engines behind the industry's historical success.
But China has increasingly moved from being primarily a source of demand to also being a major source of chemical supply.
That distinction is enormous.
Historically:
Global chemical companies → sell into China's growth
Increasingly:
Chinese chemical companies → supply China and compete internationally
McKinsey notes that China's increasing self-sufficiency is particularly challenging for European producers that historically relied on Asian export markets.
This reduces one of the industry's most important historical demand tailwinds.
Chemical plants are expensive and long-lived.
Once capacity has been built, producers have strong incentives to keep operating—even when margins are poor.
That can create a damaging cycle:
New capacity → excess supply → lower utilization → weaker prices → lower margins → weaker returns on capital
China's continued capacity additions have made this problem particularly visible in commodity chemicals.
The result is that revenue can remain relatively stable while shareholder returns deteriorate.
Chemical companies can grow revenue without creating much shareholder value if growth requires too much capital.
This is exactly the problem the sector is experiencing.
If a producer spends heavily on:
New plants
Decarbonization
Maintenance
Environmental compliance
Energy infrastructure
Technology upgrades
but cannot generate sufficient incremental returns, revenue growth becomes much less valuable.
The key metric is therefore not simply:
How fast is the company growing?
It is:
How much ROIC is that growth generating?
Energy costs have become especially important for European chemical producers.
Chemical manufacturing often requires substantial amounts of:
Natural gas
Electricity
Steam
Heat
When European energy costs remain structurally above those of competing regions, local production can become less competitive.
That has already contributed to capacity reductions and restructuring across European chemicals.
McKinsey identifies high energy prices and regional energy-price differences as important factors reshaping the industry's competitive landscape.
Chemical companies are also facing rising requirements around:
Carbon emissions
Environmental controls
Product safety
Waste management
Permitting
Decarbonization
These investments may be strategically necessary.
But they also increase the capital required to keep existing assets competitive.
For marginal commodity plants, that can make the economics increasingly difficult.
There is a common assumption that specialty chemicals automatically outperform commodity chemicals.
The long-term data is more nuanced.
McKinsey's analysis finds base chemicals and specialty chemicals generated remarkably similar long-term TSR since 2003—about 10.1% versus 9.7% CAGR, respectively.
The difference is that specialty chemicals generally exhibit lower earnings volatility.
Base chemicals have historically produced exceptional returns during specific favorable periods, including:
2003–07
2007–08
2009–11
2016–18
2020–22
Those periods were associated with specific macro and industry tailwinds such as Middle Eastern feedstock advantages and the US shale-gas boom.
So the real advantage of specialty chemicals is less "always higher returns" and more greater earnings stability and differentiated positioning.
The sector's problems do not mean every chemical company is structurally unattractive.
BCG's analysis shows significant differences between subsectors.
Industrial gases and electronic chemicals have been among the strongest performers, while chemical distribution has also maintained strong 5-, 10- and 20-year TSR performance.
Meanwhile, petrochemicals have consistently ranked among the weaker areas because of global capacity additions.
That creates a crucial investment distinction:
Chemical sector ≠ chemical subsectors.
The long-term evidence points toward two fundamental drivers:
ROIC + growth.
McKinsey's earlier research found that these two factors were the strongest determinants of chemical-company shareholder returns. Specialty-versus-commodity exposure by itself was much less important once the underlying economics were considered.
This is an important lesson.
A specialty company with poor capital discipline can destroy value.
A commodity producer with advantaged feedstock, excellent utilization and disciplined capital allocation can create substantial value.
The business model matters.
But execution matters more.
The current downturn is forcing companies to reconsider what they actually want to own.
That means:
Selling noncore assets
Closing high-cost plants
Reducing commodity exposure
Investing in differentiated products
Cutting structural costs
Consolidating production
Increasing geographic focus
The industry's restructuring wave is therefore not simply about surviving a bad year.
It is about rebuilding the portfolio around businesses capable of generating acceptable returns.
Historically, investors could reasonably expect chemicals to recover when the cycle turned.
This time, some of the industry's problems are structural.
China has added enormous capacity.
European energy economics have changed.
Supply chains are becoming more regional.
Regulatory costs are increasing.
Decarbonization requires capital.
And global demand growth is no longer providing the same effortless expansion.
McKinsey consequently warns that the industry's path forward may not follow historical norms.
The bearish argument is not the whole story.
Chemical valuations have already suffered.
And there are signs that some investors believe the sector has become too cheap.
Most recently, Ineos and its shareholders committed more than €400 million to investments in publicly traded European chemical companies, arguing that the sector is significantly undervalued after years of pressure from Chinese imports, energy costs, regulation and overcapacity.
That creates an interesting tension:
Fundamentals remain difficult—but valuations may already discount a substantial amount of bad news.
A sustained recovery would probably require more than stronger chemical demand.
The sector needs some combination of:
Capacity discipline
Excess plants need to leave the system.
Margin recovery
Supply-demand balances need to improve.
Higher ROIC
Capital spending needs to generate better returns.
Portfolio specialization
Companies need greater exposure to attractive value chains.
Feedstock advantages
Low-cost energy and raw materials remain powerful competitive differentiators.
Productivity improvements
Automation, digitalization and AI could reduce structural costs.
Better capital allocation
Companies need to resist investing simply for volume growth.
The most important question for 2026 isn't:
"Will chemicals recover?"
It's:
"Which parts of the chemical industry can still generate attractive returns in a structurally different global market?"
That distinction could separate the next generation of chemical winners from the companies that simply wait for the old cycle to return.
The chemical sector's loss of roughly two decades of relative equity-market outperformance is one of the clearest signals that the industry's economic model is changing.
The historical formula—Asian demand growth + productivity + advantaged feedstocks + portfolio expansion—is no longer sufficient.
The next phase will likely reward companies that can combine:
Structural cost advantage + disciplined capital allocation + differentiated products + resilient supply chains.
For investors, that means looking beyond sector-wide valuations.
For chemical companies, it means treating ROIC, capacity discipline and portfolio quality as strategic priorities—not merely financial metrics.
And for procurement teams, the same transformation has an operational consequence: supplier resilience and resource access may become just as important as headline product price.
The chemical industry may eventually return to outperformance.
But the evidence suggests it will have to earn it differently this time.
The global chemical sector erased roughly 20 years of relative outperformance during the recent downturn.
Structural overcapacity and weaker demand have pressured margins and ROIC.
China's growing self-sufficiency has weakened a major historical demand engine.
European producers face additional energy and regulatory disadvantages.
Specialty chemicals offer lower earnings volatility, but they have not automatically delivered superior long-term TSR.
Industrial gases, electronic chemicals and distribution remain comparatively attractive subsectors.
Future winners are likely to be defined by ROIC, growth, cost position and capital discipline.
Recent European chemical investments suggest some investors believe the sector is now materially undervalued.
Featured Product
Found this useful?
Continue Reading
Low-carbon fertilizer is moving beyond pilots as PepsiCo becomes an early commercial buyer. Explore how lower-carbon ammonia, certification, offtake agreements, and food-company demand could reshape the global fertilizer market.
Explore how precision agriculture, AI, sensors, drones, smart spraying, and advanced agrochemicals are changing crop protection and creating a new yield premium through better targeting, efficiency, and product performance.
Discover how artificial intelligence, machine learning, laboratory automation, predictive modeling, and connected data are transforming chemical R&D and helping companies develop products faster, reduce costs, and accelerate innovation.
